期刊文献+

伊班膦酸钠治疗骨转移瘤所致的疼痛 被引量:2

The therapeutic efficacy of ibandronate on metastatic bone pain
下载PDF
导出
摘要 目的观察伊班膦酸钠治疗骨转移瘤所致疼痛的临床效果。方法36例骨转移瘤伴有疼痛的病人接受伊班膦酸钠治疗,伊班膦酸钠4mg+生理盐水500ml静脉滴注,至少2h以上,每4周重复1次,3个周期后评价治疗效果。结果伊班膦酸钠治疗前骨痛评分为(6.47±2.26)分,治疗后为(3.19±2.04)分,两者相比有显著性差异(t=10.397,P<0.01),骨痛缓解有效率达72.2%,生活质量评分治疗后为(40.67±8.87)分,较治疗前(31.74±9.61)分明显上升(t=8.191,P<0.01),未见肝、肾功能损害。结论伊班膦酸钠治疗骨转移瘤所致疼痛效果好,改善了患者的生活质量。 Objective To evaluate the therapeutic effect of treatment with intravenous ( Ⅳ) ibandronate on bone pain in patients with skeletal metastases.Methods 36 patients with metastatic bone pain received IV ibandroante 4mg infused over 2 hours every 4 weeks.The therapeutic efficacy was evaluated after three circles. Results Before the treatment the mean bone pain score was 6.47 ± 2.26, after intravenous Ⅳ ibandronate the mean bone pain score was 3.19 ±2.04, the difference was significant (t = 10. 397, P 〈 0.01 ) .The response rate of pain was 72.2% .The treatment with IV ibandronate significantly improved quality of life of patients compare with baseline ( P 〈 0.01). There were no evidence of liver, renal toxicity. Conclusion The treatment with Ⅳ ibandronate has a marked analgesic effect in patients with bone pain from metastatic bone disease and improve quality of life of patients.
出处 《四川医学》 CAS 2006年第5期505-506,共2页 Sichuan Medical Journal
关键词 骨转移 伊班膦酸钠 骨痛 bone metastasis ibandroante bone pain
  • 相关文献

参考文献6

  • 1Body JJ,Mancini I:Bisphosphonates for cancer patients:why,how and when[J] ?.Support Care Cancer,2002,10:399-407. 被引量:1
  • 2孙燕主编..内科肿瘤学[M].北京:人民卫生出版社,2001:1016.
  • 3Body JJ,Diel IJ,Bell R,et al.Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer[J].Clin-Ther,2004,26(12):1947-1959. 被引量:1
  • 4Diel IJ,Body JJ,Lichinitser,et al.Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer[J].Eur-J-Cancer,2004,40 (11):1704-1712. 被引量:1
  • 5Isabelle Mancini,Jean-Claude Dumon,Jean-Jacques Body.Efficacy and safety of Ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease:a Pilot study[J].Journal of Clinical Oncology,2004,22(17):3587-3592. 被引量:1
  • 6Pechherstorfer M.Efficacy and safety of ibandronate in the treatment of neoplastic bone disease[J].Expert-Opin-Pharmacother,2004,5 (11):2341-2350. 被引量:1

同被引文献16

  • 1吴志明,栗树伟,王东.他汀类药物与骨质疏松症[J].国际骨科学杂志,2007,28(2):87-88. 被引量:14
  • 2Kastelan D,Lozo P,Stamenkovic D,et al.Preference for weekly andmonthly bisphosphonates among patients with postmenopausal osteopo-rosis:results from the Croatian PROMO Study[J].Clin Rheumatol,2009,28(3):321~326. 被引量:1
  • 3Blumentals WA,Harris ST,Cole RE,et al.Risk of severe gastrointes-tinal event s in women treated with monthly ibandronate or weekly alendr-onate and risedronate[J].Ann Pharmacother,2009,43(4):577~585. 被引量:1
  • 4Frampton J E,Perry CM.Ibandronate:a review of it s use in the man-agement of postmenopausal osteoporosis[J].Drugs,2008,68(18):2683~2707. 被引量:1
  • 5Pritchett JW.Statin therapy decreases the risk of osteonecrosis in pa-tients receiving steroids[J].Clin Orthop Relat Res,2001,(386):173~178. 被引量:1
  • 6Bauer DC,Mundy GR,Jamal SA,et al.Use of statins and fracture:results of 4 prospective studies and cumulative meta-analysis of obser-vational studies and controlled trials[J].Arch Intern Med,2004,164(2):146~152. 被引量:1
  • 7ROODMAN G D. Mechanisms of bone metastasis [ J ]. N Engl J Med, 2004, 350(16) :1655-1664. 被引量:1
  • 8YAU V, CHOW E, DAVIS L, et al. Pain management in cancer patients with bone metastases remains a challenge [ J ]. J Pain Symptom Manage, 2004, 27 ( 1 ) : 1-3. 被引量:1
  • 9BODY J J, LICHINITSER M, TJULANDIN S A, et al. Effect of oral ibandronate versus intravenous (iv.) zoledronic acid on markers of bone resorption in patients with breast cancer and bone metastases: results from a comparative phase Ⅲ trial[J]. J Clin Oncol, 2005,23 ( suppl 16 ) : 12S. 被引量:1
  • 10von MOOS R. Bisphosphonate treatment recommendations for oncologists [ J ]. Oncologist, 2005, 10 ( Suppl 1 ) : 19-24. 被引量:1

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部